Pošlji sledeče preko WhatsAppa
Nadaljuj na klepethttps://www.marketscreener.com/quote/stock/DAIICHI-SANKYO-CO-LTD-6498062/news/Daiichi-Sankyo-Initiates-Pivotal-Phase-3-Trial-of-Trastuzumab-Deruxtecan-DS-8201-in-HER2-Low-Met-27866165/?utm_source=whatsapp&utm_medium=social&utm_campaign=share